Deep Track Capital, LP 13D and 13G filings for Protagonist Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-10 4:14 pm Purchase | 2025-04-03 | 13G | Protagonist Therapeutics, Inc. PTGX | Deep Track Capital, LP | 3,250,000 5.290% | 3,250,000 (New Position) | Filing |